# Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid

> **NCT04326959** · PHASE1,PHASE2 · UNKNOWN · sponsor: **PT. Prodia Stem Cell Indonesia** · enrollment: 24 (estimated)

## Conditions studied

- Keloid

## Interventions

- **BIOLOGICAL:** Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium
- **BIOLOGICAL:** Conditioned Medium
- **BIOLOGICAL:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT04326959
- **Lead sponsor:** PT. Prodia Stem Cell Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2020-09-08
- **Final completion:** 2020-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326959, "Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04326959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*